Merck is a good place to work with great benefits - Staffing Consultant Merck Employee Review

5.0
Jan 27, 2010
Recommend
CEO approval
Business Outlook

Pros

Merck's benefits are excellent and cheap. Medical plans are heavily subsidized by the employer, with little out of pocket contribution from the employee (as compared to other Fortune 500 companies). Merck provides internal advancement opportunities. Work / Life balance can be good, but there are a lot of employees who routinely work 10+ hours per day at Whitehouse Station. As always, this varies by department / business. The Whitehouse Station HQ is a very nice facility with amenities (fitness center, health center, coffee shop, gift shop, etc). Even though it's no longer the go-go 80's, profit margins are still strong and cash flow is good. This enables Merck to invest in new technologies and make acquisitions.

Cons

SAP implementation is a huge boondoggle. The company cannot seem to stay out of the headlines. Long-timers give off the sense that everyone should want to work at Merck, so they don't make an effort to attract new talent. Novel R&D doesn't seem to be a priority, new products will probably come through acquisition rather than internal research. There is a lot of dead wood at Merck, just waiting for their full pension to kick in. There's a lot of "Merck knows best" attitude.

Explore other reviews about Merck

5.0
Jun 30, 2026
Recommend
CEO approval
Business Outlook

Pros

Excellent company to work with.

Cons

No cons encountered so far

4.0
Jun 30, 2026
Recommend
CEO approval
Business Outlook

Pros

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Cons

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

See reviews by: Helpful|Rating|Date|All